HomeNewsBusinessReal EstateCOVID-19 impact | The big daddy of Mumbai’s real estate offers 20% discount on properties
Trending Topics

COVID-19 impact | The big daddy of Mumbai’s real estate offers 20% discount on properties

A 559 sq ft property of Hiranandani has been closed for Rs 86 lakh this month. A similar unit was transacted at over a crore in March

June 16, 2020 / 22:36 IST
Story continues below Advertisement

One of the leading builders in Mumbai has decided to offer residential units at a 20 percent discount in a sign that the crushing slowdown wrought on real estate by the coronavirus pandemic might be finally forcing companies to mark down property prices.

Hiranandani Group, that has undertaken construction of iconic projects such as Hiranandani Gardens and Hiranandani Estate in Mumbai among others, sold a 559 sq ft (carpet area) unit for around Rs 86 lakh at Rs 15,472 a sq ft last week in its project One Hiranandani Park. A similar unit was sold in March — before the impact of COVID-19 was felt on the real estate industry — at a little above Rs 1 crore, or Rs 19,136 a sq ft, said people familiar with the matter.

Story continues below Advertisement

In this particular project, the company has on offer 2 BHK units of size 505 sq ft. The 559 sq ft apartment sold last week was a corner unit.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show